Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
The Journal of Infectious Diseases
|
June 16, 2007
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211
Roy M Gulick, Zhaohui Su, Charles Flexner, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 4, 2024
Current Challenges, Solutions, and Novel Directions in Research and Clinical Care: Proceedings From the 14th Annual International Workshop on HIV and Aging
Abigail Baim-Lance, Sarah Cooley, Moka Yoo-Jeong, et al.
Plos One
|
May 30, 2009
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo
Athe M N Tsibris, Bette Korber, Ramy Arnaout, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2007
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects
Nimalie D Stone, Shelia B Dunaway, Charles Flexner, et al.
Pharmaceutics
|
July 29, 2023
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
Paul Curley, James J Hobson, Neill J Liptrott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments
Ethel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211
Athe M N Tsibris, Roger Paredes, Amy Chadburn, et al.
AIDS Research and Human Retroviruses
|
March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1
Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 13, 2024
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries
N Sarita Shah, Cissy Kityo, Michael D Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2021
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus
Vincent C Marconi, Carlee Moser, Christina Gavegnano, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
The Journal of Infectious Diseases
|
June 16, 2007
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211
Roy M Gulick, Zhaohui Su, Charles Flexner, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 4, 2024
Current Challenges, Solutions, and Novel Directions in Research and Clinical Care: Proceedings From the 14th Annual International Workshop on HIV and Aging
Abigail Baim-Lance, Sarah Cooley, Moka Yoo-Jeong, et al.
Plos One
|
May 30, 2009
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo
Athe M N Tsibris, Bette Korber, Ramy Arnaout, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2007
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects
Nimalie D Stone, Shelia B Dunaway, Charles Flexner, et al.
Pharmaceutics
|
July 29, 2023
Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations
Paul Curley, James J Hobson, Neill J Liptrott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments
Ethel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211
Athe M N Tsibris, Roger Paredes, Amy Chadburn, et al.
AIDS Research and Human Retroviruses
|
March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1
Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 13, 2024
Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries
N Sarita Shah, Cissy Kityo, Michael D Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2021
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus
Vincent C Marconi, Carlee Moser, Christina Gavegnano, et al.
Page
of 14